We analyzed CD4+ T cells in a tumor-killing assay and observed that EGFRvIII-DBTE induced anti-tumor cytotoxicity by isolated CD4+ T cells at an E:T ratio of 20:1 (Figures 3G and 3H). Here, CD4 is linked to neoplasm.